Who
Colleen Sjogren
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Nuvation Bio.
In numbers
- Trades disclosed
- 6
- Buys
- 1
- Sells
- 0
- Bought
- $91K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Apr 2024
- Last trade
- 27 Feb 2026
- Last filed
- 3 Mar 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Feb 2026filed 3 Mar 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —748,130 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —748,130 at $0.00 | filing |
| 16 Jun 2025filed 18 Jun 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Bought | $91K50,000 at $1.81 | filing |
| 28 Feb 2025filed 4 Mar 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 9 Apr 2024filed 11 Apr 2024 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 9 Apr 2024filed 11 Apr 2024 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
News
Critical Review: Nuvation Bio (NYSE:NUVB) vs. OSR (NASDAQ:OSRH)NUVB · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Colleen Sjogren; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.